Arsenic exposure is associated with elevated sweat chloride concentration and airflow obstruction among adults in Bangladesh: a cross sectional study

Mi-Sun Lee,Crystal M. North,Irada Choudhuri,Subrata K Biswas,Abby F Fleisch,Afifah Farooque,Diane Bao,Sakila Afroz,Sadia Mow,Nazmul Husain,Fuadul Islam,Md Mostofa Golam,Partha Protim Biswas,David S Ludwig,Subba R Digumarthy,Christopher Hug,Quazi Quamruzzaman,David C Christiani,Maitreyi Mazumdar
DOI: https://doi.org/10.1101/2024.09.25.24314390
2024-09-26
Abstract:Arsenic is associated with lung disease and experimental models suggest that arsenic-induced degradation of the chloride channel CFTR (cystic fibrosis transmembrane conductance regulator) is a mechanism of arsenic toxicity. We examined associations between arsenic exposure, sweat chloride concentration (measure of CFTR function), and pulmonary function among 285 adults in Bangladesh.  Participants with sweat chloride greater or equal to 60 mmol/L had higher arsenic exposures than those with sweat chloride < 60 mmol/L (water: median 77.5 µg/L versus 34.0 µg/L, p = 0.025; toenails: median 4.8 µg/g versus 3.7 µg/g, p = 0.024). In linear regression models, a one-unit µg/g increment in toenail arsenic was associated with a 0.59 mmol/L higher sweat chloride concentration, p < 0.001.  We found that toenail arsenic concentration was associated with increased odds of airway obstruction (OR: 1.97, 95%: 1.06, 3.67, p = 0.03); however, sweat chloride concentration did not mediate this association. Our findings suggest that sweat chloride concentration may be a novel biomarker for arsenic exposure and also that arsenic likely acts on the lung through mechanisms other than CFTR dysfunction.
What problem does this paper attempt to address?